Announced Sat, 1 Aug · 15:41 IST
Board meeting on Aug 7 to approve Q1 results and forfeit warrants
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+3.0%1-day move
₹16.35
prior close
₹18.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-2.8-2.8-2.8-3.3+3.0+8.3+4.0+10.0+8.3+2.8-6.7-11.6——
Up moveDown movePending
AI summary
Venmax Drugs board will meet on August 7, 2026 at 4 PM to approve unaudited financial results for the quarter ended June 30, 2026 (Q1 FY27). The board will also consider forfeiture of partly paid-up share warrants from holders who did not pay the balance amount. Trading window for insiders remains closed till August 9, 2026.
Likely market impact
Watch Aug 7 for Q1 numbers and outcome of warrant forfeiture, which reduces share dilution risk.